Cypress Capital Management (Delaware)’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-5,046
Closed -$750K 167
2019
Q2
$750K Hold
5,046
0.13% 96
2019
Q1
$663K Sell
5,046
-233
-4% -$28.7K 0.12% 95
2018
Q4
$573K Hold
5,279
0.12% 100
2018
Q3
$788K Hold
5,279
0.14% 92
2018
Q2
$814K Buy
+5,279
New +$797K 0.16% 87

Other funds holding LH

Cypress Capital Management (Delaware)'s LH Position: Q3 2019 in Review

Cypress Capital Management (Delaware) sold out of Labcorp (LH) in Q3 2019, closing a stake of 5,046 shares — an estimated $750K sold.

Cypress Capital Management (Delaware) first reported a position in LH in Q2 2018 and held it in 5 quarters. The position peaked at $814K in Q2 2018. 738 funds tracked by Wall St. Rank hold LH as of Q3 2019.

  • Cypress Capital Management (Delaware) reported no remaining Labcorp position as of Q3 2019 after selling out during the quarter.
  • Cypress Capital Management (Delaware) sold 5,046 Labcorp shares in Q3 2019, an estimated $750K.
  • Cypress Capital Management (Delaware) first reported a position in Labcorp in Q2 2018 and held it in 5 quarters.
  • Cypress Capital Management (Delaware)'s Labcorp position peaked at $814K in Q2 2018.
  • 738 funds tracked by Wall St. Rank held Labcorp as of Q3 2019.

Based on Cypress Capital Management (Delaware)'s 13F filing for Q3 2019, filed 1 Nov 2019.